OPEN-LABEL EXTENSION STUDY: TEZACAFTOR/IVACAFTOR, PATIENTS ≥ 12 YEARS WITH CYSTIC FIBROSIS

被引：0

作者：

Wainwright, C. ^{[1
]}

Flume, P. ^{[2
]}

Biner, Fischer R. ^{[3
]}

Downey, D. ^{[4
]}

Brown, C. ^{[5
]}

Jain, M. ^{[6
]}

Fischer, R. ^{[7
]}

De Boeck, K. ^{[8
]}

Campbell, D. ^{[9
]}

Wang, X. ^{[9
]}

Ahluwalia, N. ^{[9
]}

Owen, C. ^{[9
]}

机构：

[1] Univ Queensland, Brisbane, Qld, Australia

[2] Med Univ South Carolina, Columbia, SC USA

[3] Lindenhofspital, Bern, Switzerland

[4] Queens Univ Belfast, Belfast, Antrim, North Ireland

[5] Indiana Univ Sch Med, Indianapolis, IN 46202 USA

[6] Northwestern Univ, Evanston, IL 60208 USA

[7] Pneumol Praxis Munchen Pasing, Munich, Germany

[8] Univ Hosp Leuven, Leuven, Belgium

[9] Vertex Pharmaceut Inc, Boston, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

TO 069

引用

页码：57 / 57

页数：1